As regulatory expectations for sterile manufacturing continue to evolve, the updated EU GMP Annex 1 guidelines have placed renewed emphasis on contamination control, risk-based validation strategies, and demonstrable patient protection. For organisations operating in fill and finish, this shift requires a validation approach supported by data and grounded in quality risk management.
Markus Junior Maring, product manager, Filtration Consumables, and Marine Cannuel, manager of validation services, Sartorius, examine how specialised validation services can help manufacturers strengthen Annex 1 compliance. Using real‑world case studies, they illustrate how collaborative, risk‑based validation approaches support effective contamination control strategies (CCS) across fill and finish operations.